Abstract
Objective
Opioid overdose is a leading cause of maternal mortality, yet limited attention has been given to the consequences of opioid use disorder (OUD) in the year following delivery when most drug-related deaths occur. This article provides an overview of the literature on OUD and overdose in the first year postpartum and provides recommendations to advance maternal opioid research.
Approach
A rapid scoping review of peer-reviewed research (2010–2021) on OUD and overdose in the year following delivery was conducted in PubMed, PsycINFO, and Web of Science databases. This article discusses existing research, remaining knowledge gaps, and methodological considerations needed.
Results
Seven studies were included. Medication for OUD (MOUD) was the only identified factor associated with a reduction in overdose rates. Key literature gaps include the role of mental health disorders and co-occurring substance use, as well as interpersonal, social, and environmental contexts that may contribute to postpartum opioid problems and overdose.
Conclusion
There remains a limited understanding of why women in the first year postpartum are particularly vulnerable to opioid overdose. Recommendations include: (1) identifying subgroups of women with OUD at highest risk for postpartum overdose, (2) assessing opioid use, overdose, and risks throughout the first year postpartum, (3) evaluating the effect of co-occurring physical and mental health conditions and substance use disorders, (4) investigating the social and contextual determinants of opioid use and overdose after delivery, (5) increasing MOUD retention and treatment engagement postpartum, and (6) utilizing rigorous and multidisciplinary research methods to understand and prevent postpartum overdose.
Significance
What is already known on this subject: Opioid overdose is a leading cause of maternal death within one year of delivery. Factors that increase susceptibility to or protect against opioid problems and overdose after delivery are not well understood.
What this study adds: Seven articles were identified in a rapid scoping review of opioid use disorder (OUD) and overdose in the year following delivery. Medication for OUD (MOUD) was the only identified factor associated with a decreased risk of postpartum overdose. Literature gaps include co-morbid conditions, interpersonal factors, and social and environmental contexts that contribute to opioid-related morbidity and mortality after delivery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
American College of Obstetricians and Gynecologists. (2018). ACOG committee opinion no 736: Optimizing postpartum care. Obstetrics and Gynecology, 131(5), e140–e150. https://doi.org/10.1097/aog.0000000000002633
Arksey, H., & O’Malley, L. (2005). 2005/02/01). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616
Asta, D., Davis, A., Krishnamurti, T., Klocke, L., Abdullah, W., & Krans, E. E. (2021). The influence of social relationships on substance use behaviors among pregnant women with opioid use disorder. Drug and Alcohol Dependence, 222, 108665. https://doi.org/10.1016/j.drugalcdep.2021.108665
Birtel, M. D., Wood, L., & Kempa, N. J. (2017). Stigma and social support in substance abuse: implications for mental health and well-being. Psychiatry Research, 252, 1–8.
Bommersbach, T., Justen, M., Bunting, A. M., Funaro, M. C., Winstanley, E. L., & Joudrey, P. J. (2023). Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review. International Journal of Drug Policy, 112, 103931. https://doi.org/10.1016/j.drugpo.2022.103931
Carpenter-Song, E., & Snell-Rood, C. (2016). The changing context of rural America: A call to examine the impact of social change on mental health and mental health care. Psychiatric Services, 68(5), 503–506. https://doi.org/10.1176/appi.ps.201600024
Chapman, S. L. C., & Wu, L. T. (2013). Postpartum substance use and depressive symptoms: A review. Women and health, 53(5), 479–503.
Cleveland, L. M., & Bonugli, R. (2014). Experiences of mothers of infants with neonatal abstinence syndrome in the neonatal intensive care unit. Journal of Obstetric Gynecologic & Neonatal Nursing, 43(3), 318–329. https://doi.org/10.1111/1552-6909.12306.
Cochran, G. T., Hruschak, V., Abdullah, W., Krans, E., Douaihy, A. B., Bobby, S., Fusco, R., Tarter, R., & Feb, J. (2018). Optimizing pregnancy treatment interventions for moms (OPTI-Mom): A pilot study. Journal of Addiction Medicine, 12(1), 72–79. https://doi.org/10.1097/adm.0000000000000370
Collier, A. Y., & Molina, R. L. (2019). Maternal mortality in the United States: updates on trends, causes, and solutions. Neoreviews, 20(10), e561–e574.
Ellis, J. D., Cairncross, M., Struble, C. A., Carr, M. M., Ledgerwood, D. M., & Lundahl, L. H. (2019). Correlates of treatment retention and opioid misuse among postpartum women in methadone treatment. Journal of Addiction Medicine, 13(2), 153–158. https://doi.org/10.1097/adm.0000000000000467
Fleming, M. F., Davis, J., & Passik, S. D. (2008). Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Medicine, 9(8), 1098–1106. https://doi.org/10.1111/j.1526-4637.2008.00491.x.
Flores, M. W., Le Cook, B., Mullin, B., Halperin-Goldstein, G., Nathan, A., Tenso, K., & Schuman-Olivier, Z. (2020). Associations between neighborhood-level factors and opioid-related mortality: A multilevel analysis using death certificate data. Addiction, 115(10), 1878–1889. https://doi.org/10.1111/add.15009
Ganann, R., Ciliska, D., & Thomas, H. (2010). Expediting systematic reviews: methods and implications of rapid reviews. Implementation Science, 5, 56–56. https://doi.org/10.1186/1748-5908-5-56.
Gemmill, A., Kiang, M. V., & Alexander, M. J. (2019). Trends in pregnancy-associated mortality involving opioids in the United States, 2007–2016. American Journal of Obstetrics and Gynecology, 220(1), 115–116. https://doi.org/10.1016/j.ajog.2018.09.028
Guille, C., Simpson, A. N., Douglas, E., Boyars, L., Cristaldi, K., McElligott, J., Johnson, D., & Brady, K. (2020). Treatment of opioid use disorder in pregnant women via telemedicine: A nonrandomized controlled trial. Jama Network Open, 3(1), e1920177. https://doi.org/10.1001/jamanetworkopen.2019.20177
Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K., & Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization - United States, 1999–2014. Morbidity and Mortality Weekly Report, 67(31), 845–849. https://doi.org/10.15585/mmwr.mm6731a1.
Harp, K. L. H., & Oser, C. B. (2018). A longitudinal analysis of the impact of child custody loss on drug use and crime among a sample of African American mothers. Child Abuse & Neglect, 77, 1–12. https://doi.org/10.1016/j.chiabu.2017.12.017
Jarlenski, M., Krans, E. E., Chen, Q., Rothenberger, S. D., Cartus, A., Zivin, K., & Bodnar, L. M. (2020a). Substance use disorders and risk of severe maternal morbidity in the United States. Drug and Alcohol Dependence, 216, 108236. https://doi.org/10.1016/j.drugalcdep.2020.108236.
Jarlenski, M. P., Paul, N. C., & Krans, E. E. (2020b). Polysubstance use among pregnant women with opioid use disorder in the United States, 2007–2016. Obstetrics & Gynecology, 136(3), 556–564. https://doi.org/10.1097/aog.0000000000003907.
Kern-Goldberger, A. R., Huang, Y., Polin, M., Siddiq, Z., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2020). Opioid use disorder during antepartum and postpartum hospitalizations. American Journal of Perinatology, 14, 1467–1475. https://doi.org/10.1055/s-0039-1694725.
Klebanoff, M. A., & Snowden, J. M. (2018). Historical (retrospective) cohort studies and other epidemiologic study designs in perinatal research. American Journal of Obstetrics and Gynecology, 219(5), 447–450. https://doi.org/10.1016/j.ajog.2018.08.044.
Kozhimannil, K. B., Casey, M. M., Hung, P., Han, X., Prasad, S., & Moscovice, I. S. (2015). The rural obstetric workforce in US Hospitals: Challenges and Opportunities. The Journal of Rural Health, 31(4), 365–372. https://doi.org/10.1111/jrh.12112.
Krans, E. E., Kim, J. Y., Chen, Q., Rothenberger, S. D., James, I. I. I., Kelley, A. E., D., & Jarlenski, M. P. (2021). Outcomes associated with the use of medications for opioid use disorder during pregnancy. Addiction, 116(12), 3504–3514. https://doi.org/10.1111/add.15582.
Krieger, N. (2014). Got theory? On the 21 st c. CE rise of explicit use of epidemiologic theories of disease distribution: A review and ecosocial analysis. Current Epidemiology Reports, 1(1), 45–56.
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031
Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. (2014). Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology: The Journal of the American Society of Anesthesiologists, 121(6), 1158–1165. https://doi.org/10.1097/aln.0000000000000472
Mair, C., Sumetsky, N., Burke, J. G., & Gaidus, A. (2018). Investigating the social ecological contexts of opioid use disorder and poisoning hospitalizations in Pennsylvania. Journal of Studies on Alcohol and Drugs, 79(6), 899–908. https://doi.org/10.15288/jsad.2018.79.899.
Mangla, K., Hoffman, M. C., Trumpff, C., O’Grady, S., & Monk, C. (2019). Maternal self-harm deaths:An unrecognized and preventable outcome. American Journal Of Obstetrics And Gynecology, 221(4), 295–303. https://doi.org/10.1016/j.ajog.2019.02.056
McKinnish, T. R., Lewkowitz, A. K., Carter, E. B., & Veade, A. E. (2021). The impact of race on postpartum opioid prescribing practices: A retrospective cohort study. BMC Pregnancy and Childbirth, 21(1), 434. https://doi.org/10.1186/s12884-021-03954-8
Metz, T. D., Rovner, P., Hoffman, M. C., Allshouse, A. A., Beckwith, K. M., & Binswanger, I. A. (2016). Maternal deaths from suicide and overdose in Colorado, 2004–2012. Obstetrics & Gynecology, 128(6), 1233–1240. https://doi.org/10.1097/aog.0000000000001695.
Mishra, G. D., Cooper, R., & Kuh, D. (2010). A life course approach to reproductive health: Theory and methods. Maturitas, 65(2), 92–97. https://doi.org/10.1016/j.maturitas.2009.12.009.
Mital, S., Wolff, J., & Carroll, J. J. (2020). The relationship between incarceration history and overdose in North America: A scoping review of the evidence. Drug and Alcohol Dependence, 213, 108088. https://doi.org/10.1016/j.drugalcdep.2020.108088
Mittal, L., & Suzuki, J. (2017). Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Subst Abus, 38(3), 261–264. https://doi.org/10.1080/08897077.2015.1129525.
Monnat, S. M. (2019). The contributions of socioeconomic and opioid supply factors to U.S. drug mortality rates: Urban-rural and within-rural differences. Journal of Rural Studies, 68, 319–335. https://doi.org/10.1016/j.jrurstud.2018.12.004
Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., & Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. https://doi.org/10.1186/s12874-018-0611-x.
Nielsen, T., Bernson, D., Terplan, M., Wakeman, S. E., Yule, A. M., Mehta, P. K., Bharel, M., Diop, H., Taveras, E. M., Wilens, T. E., & Schiff, D. M. (2019). Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. https://doi.org/10.1111/add.14825.
O’Connor, A. B., Uhler, B., O’Brien, L. M., & Knuppel, K. (2018). Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy. Journal of Substance Abuse Treatment, 86, 26–29. https://doi.org/10.1016/j.jsat.2017.12.001.
Pallatino, C., Chang, J. C., & Krans, E. E. (2019). The intersection of intimate partner violence and substance use among women with opioid use disorder. Substance Abuse. https://doi.org/10.1080/08897077.2019.1671296.
Patton, B. P., Krans, E. E., Kim, J. Y., & Jarlenski, M. (2019). The impact of medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder. Substance Abuse, 40(3), 371–377.
Peahl, A. F., Dalton, V. K., Montgomery, J. R., Lai, Y. L., Hu, H. M., & Waljee, J. F. (2019). Rates of new persistent opioid use after vaginal or cesarean birth among US women. Jama Network Open, 2(7), e197863–e197863.
Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/10.1016/j.jsat.2015.09.006
Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3), 193–201. https://doi.org/10.1016/j.drugpo.2008.10.003
Rowe, C., Santos, G. M., Vittinghoff, E., Wheeler, E., Davidson, P., & Coffin, P. O. (2016). Neighborhood-level and spatial characteristics associated with lay naloxone reversal events and opioid overdose deaths. Journal of Urban Health, 93(1), 117–130. https://doi.org/10.1007/s11524-015-0023-8.
Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., & Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics & Gynecology, 132(2), 466–474. https://doi.org/10.1097/aog.0000000000002734.
Schiff, D. M., Nielsen, T. C., Hoeppner, B. B., Terplan, M., Hadland, S. E., Bernson, D., Greenfield, S. F., Bernstein, J., Bharel, M., Reddy, J., Taveras, E. M., Kelly, J. F., & Wilens, T. E. (2021). Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2021.04.210.
Shen, Y., Lo-Ciganic, W. H., Segal, R., & Goodin, A. J. (2020). Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014. Journal of Psychosomatic Obstetrics and; Gynecology. https://doi.org/10.1080/0167482X.2020.1727882
Sillanaukee, P., Kääriäinen, J., Sillanaukee, P., Poutanen, P., & Seppä, K. (2002). Substance use–related outpatient consultations in specialized health care: An underestimated entity. Alcoholism: Clinical and Experimental Research, 26(9), 1359–1364. https://doi.org/10.1111/j.1530-0277.2002.tb02679.x
Smid, M. C., Schauberger, C. W., Terplan, M., & Wright, T. E. (2020). Early lessons from maternal mortality review committees on drug-related deaths: Time for obstetrical providers to take the lead in addressing addiction. American Journal of Obstetrics and Gynecology MFM. https://doi.org/10.1016/j.ajogmf.2020.100177
Smid, M. C., Stone, N. M., Baksh, L., Debbink, M. P., Einerson, B. D., Varner, M. W., Gordon, A. J., & Clark, E. A. S. (2019). Pregnancy-associated death in Utah: Contribution of drug-induced deaths. Obstetrics & Gynecology, 133(6), 1131–1140. https://doi.org/10.1097/aog.0000000000003279
Stone, R., & Rothman, E. F. (2019). Opioid use and intimate partner violence: A systematic review. Current Epidemiology Reports, 6(2), 215–230. https://doi.org/10.1007/s40471-019-00197-2
de Thiel, H., Braughton, M., Bradsberry, M., Howell, M., Logan, J., & Schwarz, E. B. (2017). Racial and ethnic disparities in postpartum care and contraception in California’s Medicaid program. American Journal of Obstetrics and Gynecology, 217(1), 41–47.
van Draanen, J., Tsang, C., Mitra, S., Phuong, V., Murakami, A., Karamouzian, M., & Richardson, L. (2022). Mental disorder and opioid overdose: A systematic review. Social Psychiatry and Psychiatric Epidemiology, 57(4), 647–671. https://doi.org/10.1007/s00127-021-02199-2
Wall-Wieler, E., Roos, L. L., Nickel, N. C., Chateau, D., & Brownell, M. (2018). Mortality among mothers whose children were taken into care by child protection services: A discordant sibling analysis. American Journal of Epidemiology, 187(6), 1182–1188. https://doi.org/10.1093/aje/kwy062
Wen, T., Batista, N., Wright, J. D., D’Alton, M. E., Attenello, F. J., Mack, W. J., & Friedman, A. M. (2019). Postpartum readmissions among women with opioid use disorder. American Journal of Obstetrics & Gynecology MFM, 1(1), 89–98. https://doi.org/10.1016/j.ajogmf.2019.02.004.
Wilder, C., Lewis, D., & Winhusen, T. (2015). Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug and Alcohol Dependence, 149, 225–231. https://doi.org/10.1016/j.drugalcdep.2015.02.012.
Yamamoto, A., Needleman, J., Gelberg, L., Kominski, G., Shoptaw, S., & Tsugawa, Y. (2019). Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Social Science & Medicine, 242, 112585. https://doi.org/10.1016/j.socscimed.2019.112585.
Government Accountability Office (2019). Medicaid: Opioid Use Disorder Services for Pregnant and Postpartum Women, and Children (GAO-20-40). Retrieved from: https://www.gao.gov/assets/gao-20-40.pdf
Kaiser Family Foundation (2020). Opioid Overdose Deaths by Gender. Kaiser Family Foundation. Retrived from: https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-gender/
Funding
This study was supported by the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) grant F31DA052142.
Author information
Authors and Affiliations
Contributions
JF and CM: conceptualized the review. JF: developed and implemented the search strategy, conducted data extraction, and developed the original draft of the manuscript. MJ, EK, RC, and CM: contributed to interpretation of results, revisions, and editing of the manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest
Ethical Approval
This study did not include human subjects and was exempt from review by the Institutional Review Board (IRB).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Frankeberger, J., Jarlenski, M., Krans, E.E. et al. Opioid Use Disorder and Overdose in the First Year Postpartum: A Rapid Scoping Review and Implications for Future Research. Matern Child Health J 27, 1140–1155 (2023). https://doi.org/10.1007/s10995-023-03614-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-023-03614-7